AI turns the study documents into 7 plain-language sections. The team reviews each one; only fully reviewed languages can go live
Diagnosed with type 2 diabetes mellitus with HbA1c level of 6.0 to 9.0%. Participants with HbA1c of 6.0 to 6.4% were required to be receiving oral glucose lowering medication. Diagnosed with type 2 diabetes mellitus for less than 6 years. Body mass index of 23 kg/m2 or greater.
Participants will be randomly assigned to either the intervention group or the standard care group.
You will be placed in a group at random, like a coin toss. There is a 1 in 2 chance of getting standard care.
[Paste or upload the "Possible risks" section of the EC-approved information sheet]
ClinicalTrials.gov rarely lists risks, so the AI is not allowed to guess them
Patient pages always show this next to "What you may receive"
Must match the EC-approved English information sheet, if there is one
| Question | Pass | Fail | From criterion |
|---|---|---|---|
| How long have you had diabetes? | Under 6 years | 6 years or more | Inclusion 2 |
| Which diabetes medicines? | 1–2 oral medicines | 3+ or insulin | Exclusion 1–2 |
| Latest HbA1c | 6–9% | Above 9% | Inclusion 1 |
| Kidney, liver or heart disease | Never | Yes → team review | Exclusion 8 |
| Pregnant or planning pregnancy | No | Yes | Exclusion 7 |
Criteria patients can't answer themselves (e.g. kidney labs, some blood disorders) are not asked; the team checks them at the screening visit